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ABSTRACT
Objective: To evaluate the indication of prosthesis during rehabilitation 
and the maintenance of their use or abandonment rate after discharge, 
as well as mortality of lower limb amputees due to peripheral arterial 
disease. Methods: A retrospective and cross-sectional study carried 
out with lower limb amputee patients, at transfemoral and transtibial 
levels, due to vascular conditions. The sample was composed of 310 
patients (205 men, 105 women, mean age 61.8 years), transfemoral 
(142) and transtibial (150) levels, unilateral or bilateral (18). A total of 
217 were fitted with prosthesis and 93 did not. Nonparametric statistical 
tests with equality of two proportions, 95% confidence interval and p 
value <0,05 were used. Results: Out of 195 patients we contacted, 
151 were fitted with prosthesis and 44 not. Of those that were fitted 
with prosthesis, 54 still use it, 80 abandoned and 17 died. In the group 
without prosthesis, 27 were on wheelchair and 17 died. Mortality is 
statistically higher among patients who were not fitted with prosthesis 
and 34 death occur, on average, 3.91 years after amputation. Survival 
time of patients who were not fitted with prosthesis was smaller than 
those were fitted. Conclusion: The use of prosthesis in lower limb 
amputees, due to vascular conditions, during rehabilitation is high. 
However, maintenance of prosthesis is not frequent after discharge. 
Early and high mortality is observed mainly among diabetic patients.
Keywords: Lower extremity; Peripheral arterial disease; Amputation/
rehabilitation; Amputees/rehabilitation; Peripheral arterial diseases/
complications; Prostheses and implants; Mortality
RESUMO
Objetivo: Avaliar a protetização, durante a reabilitação, e a manutenção 
do uso da prótese, e o índice de abandono da mesma após a alta, 
bem como a mortalidade dos pacientes amputados de membros 
inferiores por doença arterial periférica. Métodos: Estudo retrospectivo 
e transversal com pacientes amputados de membros inferiores nos 
níveis transtibial e transfemoral de etiologia vascular. A amostra foi 
composta por 310 pacientes (205 homens e 105 mulheres, média 
de idade de 61,8 anos), nos níveis transfemoral (142) e transtibial 
(150), unilateralmente ou bilateralmente (18). Foram protetizados 217 
pacientes e 93 não. Foram utilizados testes estatísticos não paramétricos 
de igualdade de duas proporções, intervalo de confiança para média 
de 95% (IC95%) e valor de p<0,05. Resultados: Dos 195 pacientes 
contatados, 151 haviam sido protetizados e 44 não. Dos protetizados, 
54 mantinham-se usando suas próteses, 80 haviam abandonado o 
uso e 17 faleceram. No grupo dos não protetizados, 27 continuavam 
usando cadeira de rodas e 17 tinham evoluído para óbito. A mortalidade 
é estatisticamente maior nos pacientes não protetizados e os 34 
óbitos ocorreram, em média, após 3,91 anos da amputação. O tempo 
de sobrevida dos pacientes não protetizados foi menor que o dos 
protetizados. Conclusão: A protetização de pacientes amputados de 
membros inferiores de etiologia vascular durante a reabilitação é 
alta, mas a manutenção do uso da prótese é baixa após o término 
do tratamento. A mortalidade desses pacientes é elevada e precoce, 
principalmente entre os diabéticos.
Descritores: Extremidade inferior/cirurgia; Doença arterial periférica/
complicações; Amputação/reabilitação; Amputados/reabilitação; Próteses 
e implantes; Mortalidade
INTRODUCTION
The number of lower limb amputee patients due to 
peripheral arterial disease is high in Japan, United States, 
Europe and Brazil, and the elderly population is the 
most affected.(1-6)
Despite advances in Medicine and the emphasis on 
disease prevention, amputations are still very prevalent 
in the world, and the projection is that by 2050 the 
prevalence rate will reach 3.6 million people in the 
United States alone.(7)
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The mortality rates 1 month after amputation are 
high, ranging from 15 to 30%.(8,9) After 1 year, the 
mortality rates are above 50%(9) and, after 5 years, they 
may reach up to 74%.(10) 
After the amputation, the rehabilitation program aims 
to regain autonomy for deambulation, with a prosthesis if 
possible, and also for daily activities, while taking care of 
the cognitive, emotional and social aspects.(11,12)
The rehabilitation of these patients is a challenge 
for the multidisciplinary team, because they suffer 
from other diseases associated with vascular disease, 
especially diabetes mellitus, and cardiovascular disorders, 
especially coronary heart disease, which can affect the 
survival of these individuals.(8,9,13-15) 
Follow-up studies of this population show that 
reamputations are frequent,(16-18) the abandonment rate of 
the use of the prosthesis is elevated,(19) and the mortality 
rate is high.(8,9, 20,21) 
The above data are worrisome and justify carrying 
out this study, in order to delineate the scenario of 
the department and to assist in the rehabilitation 
procedures.
OBJECTIVE
To evaluate the prosthetization, during rehabilitation, 
the acceptance and abandonment rates of the prosthesis, 
after discharge, and their causes, as well as the mortality 
rate of lower limb amputee patients of vascular etiology.
METHODS
This was a retrospective and cross-sectional study, 
based on the review of medical records of transtibial 
(TT) and transfemoral (TF) amputee patients of 
vascular etiology, followed at Lar Escola São Francisco, 
between 2003 and 2010. The review of the medical 
records was made from August to November 2011, and 
the interviews were conducted in December 2011. All 
patients or their relatives signed an Informed Consent, 
after the approval of the study by the Research Ethics 
Committee of the Universidade Federal de São Paulo 
(UNIFESP), protocol 0932/10.
The inclusion criteria for the study were: patients of 
both genders, regardless of age, lower limb amputees of 
vascular etiology followed at Lar Escola São Francisco, 
with TT and TF amputations, unilateral or bilateral, 
with or without associated diseases.
The exclusion criteria were: amputations due to 
other etiologies, non TF or TT lower limb amputations 
of vascular etiology, upper limb amputations, and 
patients with incomplete medical records.
The variables analyzed were: age, gender, side, level, 
unilateral or bilateral amputation, presence of associated 
diseases, prosthetization and, if so, acceptance or 
abandonment of the use of the prosthesis after discharge, 
and its reasons, and occurrences of deaths and their 
causes. 
The method of data analysis made use of absolute 
and relative values, non-parametric statistical tests of 
equality of two proportions, 95% confidence interval 
and p value <0.05. We used the following software: 
Statistical Package for the Social Science (SPSS) V16, 
Minitab 15, and Excel Office 2007. For the analysis of 
logistics and odds ratio, the SAS System 9.0 software 
was used.
Between 2003 and 2010, a total of 425 patients 
underwent a preliminary medical evaluation at the Group 
of Amputations and Prostheses of the Lar Escola São 
Francisco. Among these, the distribution of etiologies 
was as follows: 45 (10.6%) trauma, 15 (3.5%) infection, 
5 (1.2%) tumor, 5 (1.2%) congenital malformation, and 
355 (83 5%) had vascular etiology. Of these, 45 had non 
TF and TT amputations (the levels selected for this 
study), and were excluded. The initial sample comprised 
310 patients, of which 217 were prosthetized and 93 
were not, due to clinical events or even for physical and 
functional disabilities. (Table 1) 
For transfemoral amputee patients, the prescribed 
prostheses were modular, in steel or aluminum, with 
ischial support socket, suction valve, knee with brake 
and articulated foot; for transtibial amputee patients, 
the prosthesis were modular, in steel or aluminum, with 
KBM (condylar suspension) socket, and SACH (solid-
ankle cushion heel) foot.
Table 1. Data on review of medical records of amputee patients
Review 2003-2010 Total n (%)
Prosthetization
Yes No
n (%) n (%)
Number of patients 310 (100) 217 (70) 93 (30)
Male 205 (66.1) 147 (67.7) 58 (62.3)
Female 105 (33.9) 70 (32.3) 35 (37.7)
Mean age (in years) 61.81 62.19 61.98
Transfemoral 148 (47.8) 103 (47.4) 45 (48.4)
Unilateral right 64 (20.6) 47 (21.6) 17 (18.3)
Unilateral left 78 (25.3) 54 (24.9) 24 (25.8)
Bilateral 6 (1.9) 2 (0.9) 4 (4.3)
Transtibial 157 (50.6) 112 (51.5) 45 (48.4)
Unilateral right 70 (22.6) 51 (23.5) 19 (20.4)
Unilateral left 80 (25.8) 58 (26.7) 22 (23.6)
Bilateral 7 (2.2) 3 (1.3) 4 (4.3)
Bilateral assymetrical 5 (1.6) 2 (0.9) 3 (3.2)
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RESULTS
A total of 195 patients (62.9% of the initial sample) 
were contacted and, of these, 151 had been prosthetized 
(77.4%), and 44 had not been prosthetized (22.6%) at 
the end of rehabilitation. Of the prosthetized, 54 were 
still using the protheses, 80 had abandoned them, and 
17 had died. In the non-prosthetized group, 27 were 
using a wheelchair, and 17 had died (Table 2).
Of the 80 patients who abandoned the use of the 
prostheses, 56 were men and 24 women, mean age 
62 years. Forty were unilateral TF amputees, 38 were 
unilateral TT amputees, 1 was a TF bilateral amputee, 
and 1 as a TT bilateral amputee. Seventy-one patients 
(88.75%) used walking aids (walker, crutches or cane) 
and only 9 (11.25%) reported that they walked without 
any assisting devices. The causes for abandoning the use 
of prostheses were: 13 (16.25%) patients had difficulty 
dressing, 16 (20%) were afraid of falling, 38 (47.5%) 
patients considered the prosthesis heavy, 5 (6,25%) 
were reamputated, 2 (2.5%) reported fatigue, 1 (1.25%) 
reported ghost-limb pain, 2 (2.5%) reported dizziness, 
1 (1.25%) patient reported decompensation of blood 
pressure, 1 (1.25%) did not adapt to the prosthesis, and 
1 (1.25%) had a cerebrovascular accident (stroke).
Of the 54 patients who continued using the 
prostheses, 43 were men, and the mean age was 61.8 
years. Fifty-three were unilateral amputees (TT 32), and 
one was amputated bilaterally at the TF level. Thirty-six 
(66.7%) used walking aids, 12 (22.2%) did not use any 
resource besides the prosthesis, and 6 (11.1%) reported 
using a wheelchair for long distances.
Regarding the level of amputation and age, the 
results were similar among the groups as to contacted 
patients (89 TF, 106 TT, 61.9 years) and non-contacted 
patients (59 TF, 51 TT, 61.6 years). The frequency of 
males among contacted patients (n=140, 71.8%) was 
statistically higher than among non-contacted patients 
(n=65, 56.5%), with p=0.006.
The characteristics of the 195 contacted patients are 
shown in table 2, separating them into prosthetized and 
non-prosthetized individuals.
The mean age of the prosthetized patients was 
statistically lower than in the non-prosthetized group, 
with p=0.029 (Table 2).
In the prosthetized group, there were 17 deaths, of 
which 11 were men, and all had unilateral amputation (9 
TF and 8 TT). The causes mentioned were: 13 patients 
with acute myocardial infarction (AMI), 2 patients after 
stroke, and 2 due to infection. In the non-prosthetized 
group, 17 deaths were reported, including 13 men. Of 
these deaths, 14 occurred in patients with unilateral 
amputation (9 TF, 5 TT) and 3 in patients with bilateral 
Table 2. Comparison of characteristics of prosthetized versus non-prosthetized
Variable
Prosthetization
p valueNo 
(n=44)
Yes 
(n=151)
Total 
(n=195)
Mean age (SD) 65.2 (13.2)  61.0 (10.8) 61.9 (11.4) 0.029*
Gender
Female 14 (31.8) 41 (27.2) 55 (28.2) 0.545
Male 30 (68.2) 110 (72.8) 140 (71.8)
Transfemoral level 18 (40.9) 71 (47.0) 89 (45.6) 0.474
Unilateral right 7 (15.9) 33 (21.8) 40 (20.5)
Unilateral left 9 (20.5) 37 (24.5) 46 (23.6)
Bilateral 2 (4.5) 1 (0.7) 3 (1.5)
Transtibial 26 (59.1) 80 (53.0) 106 (54.4)
Unilateral right 11 (25.0) 38 (25.2) 49 (25.1)
Unilateral left 13 (29.6) 40 (26.5) 53 (27.2)
Bilateral 2 (4.5) 2 (1.3) 4 (2.1)
Chronic obstructive 
pulmonary disease
>0.999#
No 44 (100.0) 150 (99.3) 194 (99.5)
Yes 0 (0.0) 1 (0.7) 1 (0.5)
Arterial hypertension 0.324
No 15 (34.1) 40 (26.5) 55 (28.2)
Yes 29 (65.9) 111 (73.5) 140 (71.8)
Diabetes mellitus 0.574
No 14 (31.8) 55 (36.4) 69 (35.4)
Yes 30 (68.2) 96 (63.6) 126 (64.6)
Coronary artery disease 0.243
No 34 (77.3) 128 (84.8) 162 (83.1)
Yes 10 (22.7) 23 (15.2) 33 (16.9)
Chronic renal failure 0.118#
No 40 (90.9) 146 (96.7) 186 (95.4)
Yes 4 (9.1) 5 (3.3) 9 (4.6)
Acute arterial obstruction 0.523#
No 40 (90.9) 141 (93.4) 181 (92.8)
Yes 4 (9.1) 10 (6.6) 14 (7.2)
Chronic arterial obstruction 0.429
No 28 (63.6) 86 (57.0) 114 (58.5)
Yes 16 (36.4) 65 (43.0) 81 (41.5)
Dyslipidemia 0.663
No 36 (81.8) 119 (78.8) 155 (79.5)
Yes 8 (18.2) 32 (21.2) 40 (20.5)
Congestive heart failure 0.735#
No 41 (93.2) 142 (94.0) 183 (93.8)
Yes 3 (6.8) 9 (6.0) 12 (6.2)
Smoking 0.108
No 35 (79.5) 101 (66.9) 136 (69.7)
Yes 9 (20.5) 50 (33.1) 59 (30.3)
Mean number of 
comorbidities (SD)
2.57 (1.04) 2.66 (1.07) 2.64 (1.06) 0.531** 
Death <0.001
No 27 (61.4) 134 (88.7) 161 (82.6)
Yes 17 (38.6) 17 (11.3) 34 (17.4)
Result of the χ2 test; * result of the Student t test; # result of the likelihood ratio; ** result of th Mann-Wihitney test. 
SD: standart deviation.
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amputation (2 TF, TT 1), 12 with AMI, 4 after a stroke, 
one due to infection. 
The mortality rate was statistically higher among 
prosthetized patients, with p <0.001, and the 34 deaths 
occurred, on average, 3.91 years after amputation (standard 
deviation – SD=1.79, median=3.61, minimum=0.66, and 
maximum=8.02) (Table 3).
A logistic regression analysis was performed, as 
the model, considering as independent variables: age, 
gender, side and level of amputation, death and all the 
comorbidities separately. (Table 4)
Statistically significant effects of age (p value=0.002), 
right side (p value=0.02), chronic renal failure (CRF) 
(p value=0.05), and death (p value=0.0001) were detected. 
Age showed a negative parameter estimate (-0.06), 
indicating that the higher the age, the lower the probability 
of prosthetization. This could also be observed by the 
value of the odds ratio, which was <1 (0.94). In this 
case, each decrease of one year of age increased by 
1.06-fold the probability of prosthetization.
There was a positive parameter estimate for the 
right side (0.94), indicating that the amputation of 
the right side increased the chance of the patient 
being prosthetized. The odds ratio obtained was 10.79, 
indicating that a right side amputation increased by 
about ten times this probability.
We observed a positive parameter estimate for the 
absence of CRF (0.82), indicating that not having CRF 
increased the chance of the patient being prosthetized. 
The odds ratio obtained was 5.14, indicating that not 
having CRF increased by about five times the chance of 
the patient being prosthetized.
In relation to death, there was a statistically significant 
parameter for survival (0.91), indicating that if the patient 
Table 3. Death of prosthetized versus non-prosthetized patients
Prosthetization Estimated mean time (years)
Standard 
error
95%CI
Deaths Total Death (%) p value
Inferior Superior
No 7.32 0.83 5.70 8.94 17 44 38.64 0.001
Yes 23.63 1.12 21.43 25.82 17 151 11.26
Total 19.34 1.54 16.32 22.37 34 195 17.44  
95%CI: 95% interval confidence.
Table 4. Logistic regression of prosthetization (dependent variable) versus age, gender, side and level of amputation, all comorbidities and death (independent variables)
Variable GL Estimated parameter 
Standard 
error
Wald  
(χ2) p value Odds ratio
95%CI odds ratio 
(inferior)
95%CI odds ratio 
(superior)
Intercepto 1 10.19 757.80 0.00 0.99 - - -
Age 1 -0.06 0.02 9.22 0.002 0.94 0.90 0.98
Gender, female 1 -0.08 0.23 0.11 0.74 - - -
Side, right 1 0.94 0.40 5.71 0.02 10.79 1.50 77.49
Side, left 1 0.49 0.37 1.73 0.19 - - -
Level, transfemoral 1 0.08 0.21 0.14 0.71 - - -
COPD, absence 1 -6.46 757.80 0.00 0.99 - - -
AH, absence 1 -0.22 0.25 0.75 0.39 - - -
DM, absence 1 -0.05 0.28 0.04 0.85 - - -
Coronary artedy disease, absence 1 0.12 0.26 0.22 0.64 - - -
CRF, absence 1 0.82 0.41 3.99 0.05 5.14 1.03 25.59
AAO, absence 1 0.23 0.47 0.23 0.63 - - -
CAO, absence 1 -0.26 0.24 1.16 0.28 - - -
Dyslipidemia, absence 1 -0.19 0.26 0.53 0.47 - - -
CHF, absence 1 -0.52 0.44 1.39 0.24 - - -
Smoking, absence 1 -0.41 0.28 2.10 0.15 - - -
Survived 1 0.91 0.24 14.94 0.0001 6.16 2.45 15.50
Wald test 29.17
p value, global 0.02
AIC 203.05
Intercepto: model constant; FG: freedom grade; COPD: chronic obstructive pulmonar disease; AH: arterial hypertension; DM: diabetes mellitus; CRF: chronic renal failure; AAO: acute arterial occlusion; CAO: chronic arterial occlusion; CHF: congestive 
heart failure; AIC: Akaike information criteria; 95%CI: 95% interval confidence.
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survives, it is more probable that this patient is a 
prosthetized individual. The odds ratio obtained was 
6.16, indicating that a patient who survived was about six 
times more likely to be a prosthetic patient.
The life expectancy of non-prosthetized patients 
was lower than that of the prosthetized ones, as shown 
in figure 1.
number of amputations below the knee when compared 
to other studies conducted in the same service.(23-27) This 
change can reveal some improvement in the treatment 
of the primary disease and in the understanding, by the 
team of surgeons, of the importance of preserving the 
knee joint for the rehabilitation of the patient, as noted 
in a recent publication.(28) 
No articles were found associating the prosthetization 
of the lower limb with the amputation side, preventing 
a comparison with the results found in this study. In 
the present study, there was an association between 
the fact that the amputation occurred on the right side 
and the patient being prosthetized. The most plausible 
hypothesis is that the population of this study, in most 
cases, had right side dominance and, therefore, a better 
motor control in that side, but this information cannot 
be confirmed, as this piece of information was not 
collected or analyzed in the medical records or in the 
interviews with the patients.
The rehabilitation of these patients requires that 
the medical and therapeutic staff be very well trained to 
handle the clinical, physical, functional, emotional and 
social limitations resulting from the physical disability 
in the elderly population.(29-30,33,34)
The prosthetization at the end of the rehabilitation 
program was 70%, i.e., below the average found in 
the literature, which ranges from 75 to 95%,(11,35) but 
higher than that found in previous studies of the same 
service(23-28) and also than that described by Pohjolainen 
et al.(36)
There was no statistically significant association 
between the comorbidities assessed and the 
prosthetization (p>0.05), except for chronic renal 
failure, which had a higher percentage of positivity in 
non-prosthetized patients. Not having CRF increased 
by about five times the chance of the patient being 
prosthetized. It is known that there is great difficulty 
in compliance and participation of the dialysis amputee 
in rehabilitation programs, due to transportation 
difficulties, the need for a caregiver, and the clinical 
oscillations resulting from the hemodialysis. In this 
study, 4 of the 80 patients (5%) who abandoned the 
use of the prostheses had CRF, and none of the 54 who 
continued using the prostheses had CRF.
It could be observed that the greater the number 
of comorbidities, the lower the life expectancy of the 
patient, especially in the case of diabetes mellitus. In this 
study, among the population whose death occurred, 
diabetes was present in 67% of cases. This finding 
was confirmed in the studies of Stewart et al.(37) and 
McWhinnie et al.,(38) in which the presence of diabetes 
mellitus was shown as a marker of increased morbidity 
among amputee patients, as well as a risk factor for 
Figure 1. Kapla-Meier life expectancy graphic
DISCUSSION
Peripheral arterial diseases remain the main cause of 
lower limb amputation in the world, as described by 
several authors,(2,3,13,18,22) and the same was observed in 
our service (83%), as this study demonstrated. 
We observed a prevalence of males, representing 66% 
of the amputations, with a mean age of 62 years, similarly 
to the data from various published studies.(1-6,11,15-28)
As the results showed, the higher the age, the lower 
the chance of the patient being prosthetized. However, 
as observed in other studies,(11,12,29-32) this isolated variable 
should not be an absolute contraindication for 
prosthetic prescription, but may influence the potential 
for success in walking.
 There was a predominance of unilateral amputee 
patients, both TF (86 to 89;96.6%) and TT (102 in 
106; 96.2%). Of the 195 contacted patients, 7 (3.5%) 
were bilateral amputee patients, with 3 prosthetized (1 
TF and 2 TT) and 4 non-prosthetized (2 TF and TT 
2). The reduced number of bilateral amputee patients 
certainly contributed to the results, both regarding 
the prosthetization and the number of deaths. The 
occurrence of bilateral amputation points to a greater 
severity of the peripheral arterial disease and a poorer 
prognosis for the indication and use of prostheses.(33,34)
The distribution of the amputation levels were similar 
between TT and TF, showing the occurrence of a greater 
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shorter life expectancy after amputation, with survival 
rates around 27% at 5 years in diabetics and 40% 
among non-diabetics. De Luccia et al.(19) found even 
more alarming figures, with a survival rate at 5 years 
of 45% in diabetics and of 85% among patients with 
peripheral vascular disease, with a six times higher 
risk of mortality in diabetics. A study conducted in 
Denmark showed that the risk of not surviving 30 days 
after amputation was six times higher in patients with 
four or five comorbidities, compared to those who had 
zero or one associated disease.(9)
The life expectancy (mean=3.9 years) was lower in 
non-prosthetized patients than in prosthetized patients, 
and this did not differ much from the findings of 
Nagashima et al.,(1) Kulkarni et al.(15) and Stewart et al.(37)
In this study, the rate of death was statistically lower 
in prosthetized patients (p<0.001).
The main cause of death in both groups was AMI 
(72%), confirming the literature.(35-37,39) Colin and Collin(35) 
observed a mortality rate of 45% within 2 years, and 
75% in 4 years, 78% of cases due to AMI. Stewart et 
al.(37) observed a mortality of 60%, with 73% resulting 
from AMI, and even higher in patients with diabetes 
mellitus. In another study by Stewart and Jain,(39) heart 
disease accounted for 51% of causes of death among 
lower limb amputee patients. A study conducted in Rio 
de Janeiro(13) with 50 amputee patients showed that 36 
died in 6 years, of which 22 (61%) in the first year after 
the amputation, especially for heart problems.
It is interesting to note that only 13% of patients 
were known coronary artery disease carriers, differing 
from that found in other studies in which such values 
reached 30% at the time of the amputation.(12,14,17,18)
This finding points to the importance of a cardiac 
evaluation prior to the prescription of the prosthesis and 
justify the decision of not indicating its use in patients 
who have not been cleared by cardiologists after specific 
evaluations and exams, because it is known that there is 
a cardiac overload during the use of the prosthesis.(30,35)
After discharge from rehabilitation, an elevated 
abandonment rate of the prosthesis (62.5%) was observed, 
much higher than that found by Pohjolainen et al.,(36) 
who found an abandonment rate of the prostheses of 8% 
during a follow-up of one year, but lower than that found 
by McWhinnie et al.,(38) who showed an abandonment 
rate of 69% in 5 years, with a decrease in the daily use of 
the prosthesis from 85% to 31%. 
It was observed that many patients reported being 
more independent with the use of a wheelchair than the 
prosthesis, especially due to its weight and the difficulty 
of putting it on, always needing the help of others, in 
addition to the fact that they felt safer and less fearful 
of falling.
The rate and the reasons for abandoning the prosthesis 
that we observed should assist the rehabilitation team in 
making decisions. One factor that must be considered 
and studied in the future is the need of the use of walking 
aids. In this study, the use of walking aids was more 
prevalent among patients who had abandoned the use 
of the prosthesis, among whom 70 of 80 used a cane or 
a walker or crutches, and this may be a marker of poor 
prognosis. 
Limitations of the study
There were no data on the causes of the indications for 
amputations (critical limb ischemia, infected ulcers, 
osteomyelitis, compartmental syndrome, etc.), for there 
was no access to the medical records of the patients 
during hospitalization. There was great difficulty in 
collecting data by telephone, due to the length and 
complexity of the research protocol, especially for 
answers regarding the use of the prosthesis.
The loss to follow-up was relevant, and we contacted 
195 of 310 patients (62.9%).
Thus, an outpatient semiannual monitoring of the 
rehabilitated individuals should be taken in consideration 
in order to maintain the data from the follow-up after 
discharge from rehabilitation updated.
CONCLUSION
Lower limb prosthetization of amputee patients of 
vascular etiology during rehabilitation was high, but the 
continued use of the prosthesis was low after completion 
of treatment. The mortality and early death rates of 
these patients were high, especially among diabetics.
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